Top innovator named executive chair at ieso Digital Health
ieso Digital Health, which is developing AI-driven mental health solutions from its Cambridge base, has unveiled David Icke as executive chair to lead day-to-day management of the business and head the board.
Stemnovate and Babraham Institute come together to untangle the tauopathy in Alzheimer’s disease
An exciting research collaboration ‘sprint’ is getting ready to launch on the Babraham Research Campus to better understand the role of an essential cellular process in brain health.
Arecor announces publication of phase 1 data for AT278 in diabetes care
Ultra-concentrated, ultra-rapid acting insulin AT278, a promising candidate in the pursuit of next generation insulins to simplify and improve glycemic control
PhoreMost much more than a milestone magnet
In a matter of months Cambridge biopharma innovator PhoreMost has won a major Business Weekly award against hot competition and racked up some impressive milestones resulting from collaborations with world-class life science operators.
Axol Bioscience and French partner unveil organs-on-chip innovation
NETRI, a French neuro-organs-on-chip startup, and Cambridge biotech Axol Bioscience have agreed to commercialise novel kits in this highly specialised field; they will comprise NETRI’s organs-on-chip devices and Axol’s hiPSC-derived cells.
Rovco signs three year lease deal for multipurpose support vessel
Rovco has signed a three-year contract for the Glomar Supporter multipurpose support vessel as it looks to further expand its survey business.
Innovation Scale-Up Wazoku Agrees Acquisition of UK Idea Management Platform, Idea Drop
Innovation scale-up Wazoku has announced the signing of a binding agreement to acquire UK idea management platform, Idea Drop.
Paragraf completes lease on new Grade A industrial space
Paragraf, which specialises in the volume production of graphene-based electronic devices using standard semiconductor processes, has continued its scale-up strategy by agreeing a lease on a second Cambridgeshire facility.
Biden its time! Featurespace in line for glory in $1.6m US-UK initiative
US President Joe Biden could soon be paying homage to novel fraud busting technology from Cambridge innovator Featurespace.
Japanese funding boost to Eagle Genomics’ scale-up strategy
Japan-based corporate venture capital firm OMRON Ventures has pumped unspecified investment into Cambridge-based Eagle Genomics.
Rughani named Artfinder CEO
JOSHNA RUGHANI is the new Chief Executive Officer of online art marketplace Artfinder.
Growth Works supports Paragraf to make wonder material
Cambridge-based Paragraf, which makes ‘wonder material’ used in cars and medical diagnostics, is urging other companies to team up with Growth Works – an organisation that helped it win a £150k grant to scale the business.
Manchester spin-out that looks to revolutionise water filtration gets £500,000 funding boost
A spin-out company based at The University of Manchester that is developing a breakthrough water filtration technology, which promises to be both greener and cheaper, has secured SEED equity investment of £500,000 to help scale up.
LegalTech Apperio raises £5.75m in latest funding round
Hambro Perks has invested £2m into the London-based firm, which works with more than 60 in-house legal teams
PhoreMost taps milestone goldmine with German pharma client
Cambridge biopharma trailblazer PhoreMost, has triggered a lucrative but unspecified milestone payment in a multi-project target discovery collaboration with German giant Boehringer Ingelheim. It promises to be the first of many as the alliance rolls out.
CTO Sessions: William Jones, Sano Genetics
William Jones is co-founder of healthtech startup Sano Genetics, a medical research technology startup he founded with two fellow genomics students who he met while studying as a PhD student at the University of Cambridge.
New CTO for Sphere Fluidics
Sphere Fluidics, a Cambridge company developing single cell analysis systems, has appointed Richard Hammond as Chief Technical Officer.
Qkine raises £4.3m scale-up capital and prepares HQ move
Qkine, a Cambridge manufacturer of animal-free, highly bioactive and innovative proteins and growth factors for life science applications, has closed a £4.3 million oversubscribed funding round.
PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells.
MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform
MicrofluidX (MFX), a U.K. based provider of next-generation bioreactors for cell research and manufacturing, has announced £3.3 million ($4 million) of secured investments. This brings the company’s total funding to date to £7 million ($8.5 million).